Open original FDA record ↗Recall record
- FDA identifier
- Z-0477-2019
- Company in FDA record
- The Binding Site Group, Ltd.
- FDA classification date
- Nov 17, 2018
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
After running the calibration curve, the recovery of the IgM kit control results decrease demonstrating a reduction in accuracy within the same day; control results may be out of range one day after running the assay calibration curve. Samples have been shown to be similarly affected.
Source facts
- Action
- On 07/25/2018, the Urgent Field Safety Notice and Field Correction E-back Form were emailed to customers. Customers were advised to cease use of the affected product and to dispose of the kits locally. This notice states that a witness signature of kit disposal is required on the E-back form. This notice needs to be passed on to all those who need to be aware within your organisation or to any organisation where the potentially affected devices have been transferred. Customers with additional questions are encouraged to contact their local firm representative, or customer service via phone at +44(0) 1214569696, or email at Technical.support@bindingsite.co.uk. The E-back Form requests that each customer and witness sign and date confirming they have both received and have followed the advice issued in the Notification. It also asks for the number of product in stock and number of kits disposed.
- Initiated
- 2018-07-25
- Root cause
- Under Investigation by firm
- Terminated
- 2021-04-27
- Distribution
- U.S.: IL, WV, NE, SD, NY, IN, WA, MD, NJ, PA, NC, AR, FL, VA
- Recall number
- Z-0477-2019
- Recall status
- Terminated
- CDRH record ID
- 168646
- FDA classified
- 2018-11-17
- Recall event number
- 81409